» Go to news main
Bringing Dal‑developed cancer treatment technology to the world
A new $2.1-million investment from the federal government will help Dal researchers build on advances in precision cancer-treatment technology and bring them more quickly to patients in need around the world.
Faculty of Medicine researcher James Robar, chief of Medical Physics at the Nova Scotia Health Authority (NSHA) and director of Dal’s Medical Physics program, and his team will use the funds to expand their work on developing and improving technologies that allow doctors to deploy radiation treatment in more precise, less-invasive ways that improve patient outcomes.
Dr. Robar provided attendees with a brief overview of each technology. They range from a capacitive patient-monitoring system that provides sensitive readouts many times a second about where a patient is during treatment to an algorithm that can enable more precisely target radiation treatments that result in less damage to surrounding healthy organs and tissue.
“We know that we have to move beyond and further than publishing papers and theses because we want these ideas to reach and benefit patients,” said Dr. Robar, crediting Brainlab for its help in giving his team a channel for technologies that “began as ideas on a whiteboard.”
Read more on Dal News.
- CADTH Recognizes Rising Star Dr Michelle Mujoomdar
- Dal internist co‑authors paper for The Lancet on Canada’s health leadership obligations
- Molly Appeal to support advanced brain research with new tissue processing machine
- Entering the Den for a research prize
- Dal Med Innovator | Dr. Lea Steeves
- U.S. National Institutes of Health (NIH) awards Dal‑led project $3.2 million to develop new immunotherapy drugs for advanced melanoma
- New Canada 150 Research Chair in Vaccinology and Global Health to Call Dalhousie Home
- Dalhousie Original | Dr. Ford Doolittle